Medical NanoViricides Announces that Clinical Trials of Its Broad-Spectrum Antiviral Drug NV-CoV-2 Have BegunBy Marie JonesJune 29, 2023 NanoViricides, Inc. (NYSE American:NNVC) (the Company) reports that clinical trials of its broad-spectrum antiviral drug NV-CoV-2 began on June 17,…
